I en populations- farmako - kinetisk undersøgelse medførte et 47% fald i fedtfri legemsvægt- justeret creatinin- clearance et 17% fald i raloxifenclearance og et 15% fald i clearance af raloxifen- konjugater.
In a population pharmacokinetic study, a 47% decrease in lean body mass adjusted creatinine clearance resulted in a 17% decrease in raloxifene clearance and a 15% decrease in the clearance of raloxifene conjugates.